Open2.070 | Close- |
Vol / Avg.18.653K / 67.204K | Mkt Cap2.529M |
Day Range2.070 - 2.219 | 52 Wk Range1.770 - 15.000 |
Adial Pharmaceuticals Stock (NASDAQ: ADIL) stock price, news, charts, stock research, profile.
Open2.070 | Close- |
Vol / Avg.18.653K / 67.204K | Mkt Cap2.529M |
Day Range2.070 - 2.219 | 52 Wk Range1.770 - 15.000 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -1.130 | -1.140 | -0.0100 | ||||
REV | 0 |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -1.500 | -1.330 | 0.1700 | ||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-07-11 | Brookline Capital | Kumaraguru Raja | Reiterates | BuyBuy | Maintains | - | 6.00 |
2022-08-17 | Maxim Group | Jason McCarthy | Downgrades | BuyHold | - | - | - |
2021-10-13 | Brookline Capital | Kumaraguru Raja | Initiates Coverage On | Buy | Announces | - | 12.00 |
2021-06-29 | Litchfield Hills | - | Initiates Coverage On | Buy | Announces | - | 5.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
ADIL | Adial Pharmaceuticals | 2.8% | 2.5M |
CING | Cingulate | -4.29% | 3.3M |
TTNP | Titan Pharma | 3.34% | 4.7M |
SXTP | 60 Degrees | 3.45% | 4M |
KPRX | Kiora Pharmaceuticals | -2.06% | 4.1M |
You can purchase shares of Adial Pharmaceuticals (NASDAQ: ADIL) through any online brokerage.
Other companies in Adial Pharmaceuticals’s space includes: Cingulate (NASDAQ:CING), Titan Pharma (NASDAQ:TTNP), 60 Degrees (NASDAQ:SXTP), Kiora Pharmaceuticals (NASDAQ:KPRX) and Akanda (NASDAQ:AKAN).
The latest price target for Adial Pharmaceuticals (NASDAQ: ADIL) was reported by Brookline Capital on Tuesday, July 11, 2023. The analyst firm set a price target for 6.00 expecting ADIL to rise to within 12 months (a possible 188.95% upside). 1 analyst firms have reported ratings in the last year.
The stock price for Adial Pharmaceuticals (NASDAQ: ADIL) is $2.0765 last updated Today at December 8, 2023 at 3:18 PM UTC.
There is no dividend information for Adial Pharmaceuticals.
Adial Pharmaceuticals’s Q3 earnings are confirmed for Tuesday, November 14, 2023.
There is no upcoming split for Adial Pharmaceuticals.
Adial Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.